MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Idiopathic Parkinson’s disease and Normal pressure Hydrocephalus – a tale of two sisters

    P. Vvsrk, S. Kola, R. Alugolu, R. Kandadani, R. Borgohain (Hyderabad, India)

  • If Oral Levodopa is not Possible, Keep Calm and Breathe Deeply

    D. García-Meléndez, E. Gisbert Tijeras, B. Carmona Moreno, E. Botia Paniagua (Alcázar San Juan, Spain)

  • IGF2 Induce Neuroprotection in PD Preclinical Models by Modulation of Immune Response.

    FG. Grünenwald, MC. Cisternas, DS. Sepulveda, TH. Huerta, CJ. Jerez, RP. Pacheco, RLV. Vidal (Santiago, Chile)

  • ilex Paraguariensis (Yerba mate) modulates the AMPK pathway and downstream key metabolic mechanism that may explain its neuroprotective role.

    J. Ferrario, H. Hauche, L. Tschopp, T. Eidelman, M. Bordone (Buenos Aires, Argentina)

  • Image-guided Programming versus Conventional Programming in Deep Brain Stimulation: Comparative Study of a Parkinson’s Disease Cohort and Subthalamic Neurostimulation

    A. Neves, L. Sousa, M. Rito, C. Chamadoira, J. Massano, M. Rosas, C. Soares (Porto, Portugal)

  • Imaging the Nigrostriatal Pathway in Patients with Idiopathic Normal Pressure Hydrocephalus and Parkinsonism

    G. Palermo, A. Francesconi, G. Bellini, R. Morganti, G. Migaleddu, D. Di Carlo, P. Perrini, N. Benedetto, C. Pacchetti, D. Volterrani, M. Cosottini, R. Ceravolo (Pisa, Italy)

  • Imaging-based Troubleshooting Deep Brain Stimulation in Parkinson’s Disease

    J. Yamamoto, I. Paraguay, R. Barbosa, E. Barbosa, R. Cury (Sao Paulo, Brazil)

  • Immune cell traits and Parkinson’s disease: A Mendelian randomization study

    JL. Wang, Y. Fang, YL. Li, R. Zheng, Y. Chen, J. Tian, XZ. Yin, JL. Pu, BR. Zhang (Hangzhou, China)

  • Immunomodulatory Effects Of Covid-19 Vaccination On Inflammatory And Neurotrophic Factors In Parkinson’s Disease: Insights From Clinical Subtypes

    J. Salimjonov, N. Rashidova, KH. Khalimova, R. Matmurodov (Tashkent, Uzbekistan)

  • Immunoproteasome subunits as emerging contributors to neurodegeneration in Parkinson’s Disease

    HD. Nguyen, YE. Kim (Anyang-si, Gyeonggi-do, Republic of Korea)

  • « Previous Page
  • 1
  • …
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley